Treatment of cheilitis is usually difficult and often disappointing. We evaluated the effects of a topical preparation containing vitamin E acetate (VEA® lipogel) in 254 patients (mean age, 29.5) with cheilitis of various nature and etiology, involving the vermilion region and/or the perioral skin. The most frequent form of cheilitis was that induced by oral isotretinoin; other forms were irritant contact dermatitis, atopic cheilitis, and contact allergy. Patients were instructed to apply VEA® lipogel daily; the number of daily applications was modulated on the basis of the severity of symptoms (two or three times a day in the majority of cases). After 4 weeks of treatment, clinical examination showed that the severity of symptoms and signs significantly improved (p<O.OOl). The response to treatment was reported as particularly rapid by 32% of patients. Patient's assessment of overall effectiveness and acceptability was positive in the majority of cases. Treatment was well tolerated; local adverse reactions were observed in 2.75 % of patients and were mostly transient and mild. Our experience suggests that VEA® lipogel is an effective and safe approach to cheilitis. The safety of this preparation is also due to the presence of only a few excipients and the absence of fragrances, preservatives and colouring agents.
Cheilitis is an acute or chronic inflammatory disorder of the lips, limited to the vermilion area, which often extends to the nearby skin (1-3). The term cheilitis refers to numerous conditions with variable nature and etiology. In common practice, the most frequent forms include cheilitis associated with the use of oral retinoids (especially isotretinoin) and eczematous cheilitis, namely irritant contact dermatitis (ICD), allergic contact dermatitis (ACD) and atopic (endogeous) eczema (4-18).
We wanted to evaluate the effectiveness and tolerability of a topical preparation containing vitamin E acetate (VEA® lipogel) in patients with cheilitis of various type. patients but one who prematurely discontinued the use of the lipogel after the development of an eczematous reaction at the site of application. The frequency of daily applications of YEA lipogel was variable (Tab. II), but most patients applied the lipogel for 2-3 times/day. After 4 weeks of treatment, a significant reduction (p<O.OO 1) in the severity of each clinical parameter was noted ( Fig. 1) . Clinical response was considered extremely rapid (within 10 days) by 81 patients (32%) and unsatisfactory in 4 cases; reasons for ineffectiveness in these cases were active treatments were interrupted at least 2 weeks prior to the study start (baseline). Patients were instructed to apply daily VEA® Iipogel (Hulka, Rovigo, Italy) on the affected areas for 4 weeks and to modulate the number of daily applications as needed. Topical or systemic treatments apt to interfere with symptoms and signs of cheilitis were prohibited during the study period.
MATERIALS AND METHODS

Subjects
Patients were visited at the baseline (TO) and after 4 weeks of treatment (T I). Clinical evaluation was performed using a 4-score rating scale (0= absent; 1= mild; 2= moderate; 3= notable) to assess the severity of the following parameters: xerosis/scaling, erythema, fissuring, papulation/oozing/crusting, and burning/ pruritus.
Wilcoxon's matched-pairs signed-ranks test was used for statistical evaluation at the post-treatment visit versus baseline; statistical significance was defined as p<0.05.
Patients and physicians independently gave their judgement on the efficacy of the treatment. Patients were also asked about treatment acceptability.
RESULTS
Two hundred and fifty-four (139 female and 115 male) subjects, aged 1 to 85 years (mean, 29.5), entered the study. They suffered from different types of cheilitis, as shown in Tab. I. Atopic diathesis in forms different from atopic cheilitis was present in 13 patients (8 with cheilitis from oral isotretinoin, 3 with ICD and 2 with ACD). The localization of cheilitis was the vermilion associated with the perioral skin in 108 subjects, the vermilion alone in 93 cases, and the perioral skin alone in 53 subjects. In the study population, there were acute, subacute and chronic forms of cheilitis. The duration of cheilitis was of' 1-2 weeks in 89 cases, 1 month in 38, 2-3 months in 33, and various months/years in 73 cases; 21 patients did not remember the period of onset. One hundred and fifty-five patients had previously used topical treatments for cheilitis: emollients (85 patients), corticosteroids (57), antibiotics (9), and antifungal agents (4). Unsatisfactory results had been obtained with emollients in 73 cases and with steroids in 29 subjects, whereas 15 patients reported good but short-term results after treatment with corticosteroids.
Treatment was regularly completed by all poor compliance, association with candidiasis, increase of daily dosage of isotretinoin, and the presence of lichen planus. Local adverse reactions were reported by 7 patients (2.75%); apart from the above-mentioned reaction which resulted in early cessation of treatment, these were mild and transient in all cases. They consisted of burning sensation in 4 cases (1.6%) and worsening of burning or erythema in 2 patients (0.8%).
The opinion on efficacy and acceptability of treatment was positive in the majority of cases and is summarized in Tab. III.
DISCUSSION
Vitamin E acetate is an esterified form of vitamin E, the most important lipophilic antioxidant. Recent evidences have shown that vitamin E acetate is converted into vitamin E in human skin (9-10), although the delivery and bioavailability appear to be dependent on the formulation (11) . Vitamin E and its derivatives are potent inhibitors of oxidative stress and lipid peroxidation and have various biological effects, such as antifibrotic, antiinflammatory and photoprotective activities (10, 12) . It has been demonstrated that vitamin E increases the stratum corneum hydration and waterbinding capacity of the skin (13) . For the hydrating effect the concentration seems to be of crucial importance (13) .
The results obtained in our experience indicate that a preparation containing vitamin E acetate is effective and well tolerated in the treatment of cheilitis. Study treatment caused a relevant improvement of cheilitis within 4 weeks in the majority of patients and within 10 days in 32% of cases. Notably, 102 patients were not satisfied with previous emollient or corticosteroid treatments, including patients treated with oral isotretinoin which constantly induces a typical cheilitis.
Treatment of cheilitis is commonly difficult. Emollients are often used in order to induce symptomatic relief, but the response may be poor and unsatisfactory, and topical corticosteroids are not suitable for the long-term management. Moreover, the regular use of emollients in chronic or recurrent forms can augment the risk of exposure to irritant substances contained as excipients. It is worth mentioning that VEA lipogel contains only four excipients and is devoid of fragrances, colouring agents and preservatives.
